What You Should Know: 

– DeepScribe, an innovator in ambient AI documentation for healthcare, announced the appointment of Dr. Dean Dalili, MD, MHCM, as its new Chief Medical Officer (CMO). 

– Dr. Dalili brings a wealth of experience to DeepScribe, poised to play a pivotal role in shaping the company’s clinical strategy and advancing its mission to revolutionize healthcare documentation.

Guiding DeepScribe’s Clinical Leadership

As CMO, Dr. Dalili will spearhead DeepScribe’s clinical strategy, focusing on three key areas:

• Enhancing Enterprise-Grade AI: Dr. Dalili’s expertise will be instrumental in refining DeepScribe’s AI technology, ensuring it delivers the highest standards of accuracy and clinical relevance.
• Building Strategic Partnerships: Leveraging his extensive network, Dr. Dalili will foster critical partnerships with healthcare organizations to facilitate widespread adoption of DeepScribe’s solutions.
• Driving Industry Impact: Dr. Dalili’s leadership will propel DeepScribe’s mission to transform healthcare documentation and improve patient care delivery.

Dr. Dalili Bio/Background

Dr. Dalili boasts an impressive two-decade career spanning clinical practice, academia, healthcare policy, and industry leadership. Prior to joining DeepScribe, he served as President of Market Operations at DispatchHealth, a tech-enabled healthcare startup, where he spearheaded operational excellence. He also held executive positions at Envision Healthcare and SCP Health, overseeing physician networks across 800 hospitals and health systems. Throughout his career, Dr. Dalili has consistently demonstrated success in population health management, improving clinical quality, and reducing healthcare costs.

"We are thrilled to welcome Dr. Dalili to our executive team," said Akilesh Bapu, CEO and Co-Founder of DeepScribe. "His extensive experience as a physician leader and his track record of driving healthcare innovation will be invaluable as we work to transform medical documentation and improve patient outcomes. With Dr. Dalili's guidance, we anticipate accelerating our product development, ensuring the highest standards of clinical accuracy, and delivering even greater value to our healthcare partners."

What You Should Know

– Vytalize Health, a risk-bearing provider enablement platform, welcomes three new executives as the organization continues to pioneer the future of value-based care delivery.

– The leadership additions reinforce Vytalize Health’s commitment to providing innovative tools and support that enable physician partners nationwide to work more efficiently while continuing to deliver high-quality, personalized care to patients.

Key Leadership Additions to Support Continued Excellence in Value-Based Care 

The three new executive hires are:

Sherry Slick, CHCIO, CPHIMS – Chief Information Officer (CIO): Slick brings over three decades of experience in the health I.T. field and a passion for leveraging technology to create exceptional patient experiences. Most recently, she served as CIO at the Indiana Hemophilia & Thrombosis Center. Previously, she was CIO of Marathon Health. In addition, she was founder and CEO of AchieveEHR, a successful consulting practice focused on electronic health records. 

Charles Colligan, Chief Financial Officer (CFO): With a background ranging from investment banking on Wall Street to holding key financial leadership roles at Aledade, CoStar Group, and Sallie Mae, Colligan brings over 30 years of invaluable experience guiding the financial and operational performance of various organizations. He recently steered Coronis Health through a successful acquisition by Veritas Capital, showcasing his ability to direct healthcare organizations through pivotal growth phases and transactions. 

Hirsh Sandesara, MD, MBA – SVP of Clinical Performance: A proven physician executive, Dr. Sandesara integrates clinical, business, and analytics expertise to improve quality and drive care delivery transformation. He joins Vytalize Health from Blue Cross NC, where he served as lead medical director for value-based provider engagement. He is a board-certified emergency physician with direct clinical care experience, most recently as an attending with Wake Emergency Physicians, PA. His extensive experience also includes positions as a business analyst at McKinsey and Senior Product Manager at Express Scripts. 

What You Should Know: 

– Availity, the nation’s leading real-time health information network, has announced the appointment of Sean Barrett as its new Chief Product Officer. 

– Barrett boasts a distinguished background in healthcare technology, with a proven track record of driving innovation.  He will spearhead Availity’s product strategy and development, ensuring their solutions continue to meet the ever-evolving needs of both healthcare providers and payers.

Barrett Bio/Background

Prior to joining Availity, Barrett held key leadership positions at prominent healthcare organizations such as R1 and Deloitte Consulting.  In these roles, he played instrumental parts in developing and implementing innovative strategies for provider operations.  His specific experience in revenue cycle management and strategic operations uniquely positions him to drive impactful product initiatives for Availity.

What You Should Know: 

– Transcarent, the One Place for Health and Care appoints Laurie McGraw as Executive Vice President. 

– Reporting to CEO Glen Tullman, Ms. McGraw will support Transcarent’s commercial endeavors across business and channel development.

McGraw Bio/Background

Ms. McGraw is a leader with experience in healthcare innovation, holding positions at the American Medical Association (AMA) and Allscripts.  She is a champion for health equity and women’s leadership, serving on various boards and launching the Inspiring Women podcast. Ms. McGraw holds a degree in Cognitive Science from Brown University.

“Throughout my career I have always been inspired to dream big, work hard, and make a difference,” said McGraw. “Transcarent has a bold and important vision for the industry. Somebody needs to take the lead in reinventing healthcare and I’m excited to join the amazing team at Transcarent on their mission to make it easy for people to access high-quality, affordable health and care.”

What You Should Know: 

– Define Ventures, the leading early-stage investor in digital health companies, announced today the appointment of Frank Williams as Venture Partner. 

– Williams, a seasoned entrepreneur and healthcare executive, brings a wealth of experience to the firm, playing a key role in supporting and scaling their portfolio companies.

Williams Bio/Background

Williams boasts an impressive career in healthcare, highlighted by his co-founding role at Evolent Health.  During his tenure as CEO and Chairman, Evolent completed an IPO, achieved over $1 billion in annual revenue, and served more than 15 million patients.  Prior to Evolent, Williams served as Chairman and CEO of The Advisory Board Company, leading them through another successful IPO and significant revenue growth.

Williams’ current commitments demonstrate his continued dedication to healthcare innovation. He sits on the boards of influential companies like Helix, Nayya, and Wellth, and holds leadership positions at UCSF, ICER, and Brown University.

Define Ventures: Investing in the Future of Digital Health

With $800 million in assets under management, Define Ventures partners with digital health companies at various stages, from incubation to Series B funding.  They are known for their “high conviction, hands-on approach,” offering entrepreneurs a valuable network and expertise to drive tangible results.  Define Ventures has partnered with over 20 companies, including industry leaders like Hims & Hers and Unite Us.

What You Should Know:

– Phreesia, a provider of patient intake, outreach and activation appoints Jack Callahan as the company’s new Chief Technology Officer.

– As Chief Technology Officer, Callahan will oversee Phreesia’s core and integration platforms and is responsible for the company’s Patient Intake, Data Center Operations, Site Reliability Engineering and Analytics teams. 

Callahan Bio/Background

Callahan previously served as Phreesia’s Vice President of Engineering and has been with the company for 14 years. He succeeds Dan Nathan, who has been with the company for 17 years and played an integral role in establishing Phreesia’s technical capabilities. Nathan will remain with the company as Senior Engineering Advisor.   Callahan joined Phreesia in 2010 as an engineer and has served in many roles during his tenure, most recently, Vice President of Engineering. Prior to joining Phreesia, Callahan was a Developer and Architect at Spotfire, where he worked on the professional services team and helped clients from a wide range of industries gather and analyze their data.  

What You Should Know:

– Somnee, a provider of personalized sleep technology using non-invasive brain stimulation, today announced the appointment of Tim Rosa as Chief Executive Officer (CEO).

– Rosa brings over 20 years of experience in building and scaling consumer brands, making him well-positioned to lead Somnee’s mission to help people achieve better sleep through personalized neuroscience.

– As the consumer sleep market continues to see record growth, Rosa’s immediate focus will be raising the company’s next round of funding, building brand awareness, spearheading the near-term launch of multiple new products and service enhancements, and further solidifying Somnee’s position as a pioneering leader in sleep fitness and other neurological health disorders.

What You Should Know:

– XiFin, Inc., a pioneering force in healthcare information technologies, has announced the appointment of Erik Sallee as its new Chief Financial Officer (CFO) and Executive Vice President.

– With a wealth of experience in finance and a track record of success in leading organizations through transformative growth phases, Sallee’s arrival marks a significant milestone for XiFin as it charts its course towards enhanced operational efficiency and market expansion.

Sallee Bio/Background

Sallee brings with him a distinguished career history, having previously served as CFO at Intuitive Machines, a renowned space exploration company. During his tenure, he played a pivotal role in guiding Intuitive Machines through its Series B funding round to a successful public listing on the NASDAQ, solidifying its position as a key player in the space industry.

His appointment comes at a crucial juncture for XiFin as the company gears up for accelerated growth and pursues strategic opportunities in the dynamic healthcare landscape. Drawing from his extensive experience in finance, including senior positions at leading organizations such as Raytheon Solipsys, L3 Technologies, and Blue Origin, Sallee is well-positioned to drive XiFin’s financial strategies forward with agility and foresight.

Sallee’s diverse background, which spans from serving in the U.S. Marine Corps to holding executive finance roles across various industries, underscores his versatility and adaptability in navigating complex business environments. His academic achievements, including a Bachelor of Science in Political Science from Vanderbilt University and advanced degrees in Finance from the University of Maryland College Park, further augment his credentials.

“I’m proud to be joining XiFin’s mission-driven team to shape the future of healthcare,” said Sallee. “XiFin’s success is rooted in delivering cutting-edge technology and exceptional value that empower our customers to provide the best possible healthcare. I look forward to working with XiFin’s visionary leaders to advance this thriving business model and capitalize on our growth opportunities.”

What You Should Know:

– Calibrate, the leading clinician-guided and value-based obesity treatment program, today announced the appointment of Rob MacNaughton as its new Chief Executive Officer.

– Calibrate’s strategic direction under MacNaughton’s leadership and the OptumRx partnership position the company for significant growth and a positive impact on both individual and corporate healthcare landscapes.

MacNaughton Bio/Background

MacNaughton boasts a distinguished track record in launching new healthcare ventures, overseeing product development, and scaling operations. Prior to Calibrate, MacNaughton served as Venture Chair at Redesign Health, overseeing the launch and growth of several healthcare delivery and technology brands. His previous roles include CEO positions at Curve Health and Nurse Grid, and Chief Product Officer at Cambia Health Solutions, a multi-state Blue Cross Blue Shield payor.

“Obesity is the largest category of chronic disease and one of the biggest drivers of healthcare spending. I’m honored to join a company at the forefront of value-based obesity care and a business that is clearly committed to addressing the epidemic head on while helping employers and insurers manage soaring costs,” said Calibrate CEO, Rob MacNaughton. “Our commercial momentum is stronger than ever, and we are confident we will continue to collaborate with industry leaders to deliver best-in-class sustained outcomes.”

What You Should Know:

– Nabla, the leading ambient AI assistant for healthcare professionals, announced the appointment of Dr. Ed Lee, MD, MPH, as Chief Medical Officer.

– As Chief Medical Officer, Dr. Lee will shape Nabla’s clinical strategy and product roadmap. He will contribute to feature enhancements, advocate for Nabla at industry events, and provide valuable insights on clinical informatics trends.

Dr. Lee Bio/Background

Dr. Lee joins Nabla with over 20 years of experience as a board-certified internal medicine physician. Notably, he served as Executive Vice President of IT and Chief Information Officer for The Permanente Federation, overseeing technology initiatives and innovation for Kaiser Permanente’s physician-led medical group, the largest in the US. He also spearheaded the successful implementation of Nabla Copilot at TPMG, demonstrating the solution’s effectiveness in reducing documentation burden for 10,000 physicians.

“I believe technology is the key to solving the clinician burnout crisis and removing burnout will ultimately result in higher quality care for patients,” said Dr. Lee. “My experience implementing Nabla Copilot was so effective and monumental that my ultimate goal is to get it in the hands of as many clinicians as possible across the country. I’m eager to share my experiences and help other clinical teams take advantage of our solution so they can remain focused on delivering high-quality care.”

What You Should Know:

– Verily, an Alphabet precision health technology company appoints Myoung Cha as Chief Product Officer.

– As Chief Product Officer at Verily, Cha will lead strategy and development across the company’s care (Verily Onduo), research (Verily Viewpoint), and products (Verily Numetric) portfolio.

Cha Bio/Background

Cha has more than twenty years of experience building and implementing innovative technology solutions to advance clinical research, transform patient experiences, and deliver more personalized care. Cha joins Verily from Carbon Health where he served as President and Chief Strategy Officer. In that role, he was responsible for the primary care, virtual care, and mental health service lines and led market access and health system partnerships. He also built and led cross-functional product, engineering, design, clinical, and operations teams to deliver novel primary care models and build new technology-enabled programs and capabilities. 

Prior to Carbon Health, Cha was Head of Health Strategic Initiatives at Apple leading the development and launch of several health engagement technologies focused on improving the health and wellbeing for consumers around the globe, including mobile applications for Apple Watch. Cha also led research studies with leading healthcare organizations, including on atrial fibrillation and early detection of stroke using Apple Watch, and co-developed exposure notification technology with Google to support the COVID-19 pandemic response. Before Apple, he was a Partner at McKinsey & Co where he led McKinsey’s Global Healthcare Strategy & Privacy Equity practices. 

“What excites me about Verily is the unique opportunity we have to advance precision health with the company’s diverse combination of talent, technology, and capabilities,” said Myoung Cha. “Verily’s approach to close the gap between research and care will not only accelerate novel therapies but also generate more robust evidence, resulting in earlier detection and more proactive management of health conditions.” 

What You Should Know: 

– Doxy.me, a telehealth platform dedicated to making telemedicine accessible to all, announced the appointment of Esteban López, MD, MBA, as its new Chief Medical Officer (CMO), effective February 5, 2024.

– As CMO, Dr. López will lead Doxy.me’s Growth Department, strategically expanding its reach in the US, particularly underserved communities, and growing its international presence.

Dr. Lopez Bio/Background

Dr. López brings over two decades of healthcare leadership experience and a commitment to leveraging technology to improve access and quality of care, aligning perfectly with Doxy.me’s mission. Prior to joining Doxy.me, Dr. López held leadership positions at Google Cloud and Health Care Service Corporation (HCSC), where he successfully implemented technology solutions to improve healthcare services. As a board-certified internist and pediatrician, he brings deep clinical understanding to the table. Moreover, his commitment to innovation is evident in his certificate in leading digital transformation in healthcare from Harvard Medical School.

“As a physician, my primary focus in leading growth will be ensuring doxy.me remains laser-focused on serving its core customers – healthcare professionals and administrators,” said Dr. López. “This is a particularly exciting opportunity for me because our goals are deeply aligned. I am passionate about reducing health inequities and disparities, and doxy.me

What You Should Know:

– Healthy.io, the pioneer of smartphone-powered at-home kidney testing, announced Geoff Martin, a seasoned healthcare executive, will take the reins as CEO, while founder Yonatan Adiri transitions to the role of President.

– This move marks a pivotal moment for the company as it enters a new phase of growth, aiming to expand its reach and impact on global healthcare.

Martin’s Proven Track Record for Growth

Geoff Martin brings extensive experience in commercializing healthcare innovations. As president of Olive, he led the successful sale of its insurance division, and prior to that, he served as the global CEO of GE Healthcare’s Partners group. His expertise in scaling businesses and navigating complex healthcare markets will be invaluable to Healthy.io’s growth ambitions.

Adiri Charts the Long-Term Vision

Adiri, who has led the company since its inception, will now focus on shaping Healthy.io’s long-term strategy and forging partnerships with public health systems and financial institutions. His passion for democratizing healthcare and his deep understanding of the market will remain crucial to the company’s success.

“We have irreversibly changed the world of digital medicine,” declared Adiri, expressing pride in Healthy.io’s achievements. “With Geoff at the helm, we are poised to accelerate our impact and reach millions more patients around the world.”

Zohar: Advancing AI and Global Partnerships

Co-founder Ron Zohar, who previously led product development, will join the Board and spearhead the company’s next generation of advanced AI. He will also focus on forging global partnerships to fuel Healthy.io’s growth strategy.

What You Should Know:

– Healthcare engagement leader Icario has tapped industry veteran Aerste Howells as its new Chief Commercial Officer, effective January 2nd, 2024.

– Reporting to CEO Marc Willard, Howells will spearhead Icario’s sales and marketing efforts, collaborating with healthcare executives to leverage the power of engagement in driving healthy behaviors.

Aerste Howells Bio/Background

Howells brings over two decades of experience partnering with payers, providers, and employers to integrate innovative care services into their organizations. Her most recent success story lies with Cureatr, a value-based medication management clinic. As Chief Revenue Officer, she spearheaded sales, account management, and implementation initiatives, driving annual revenue from $3.1M in 2022 to a projected $40M in 2024.

Prior to Cureatr, Howells served as Senior Vice President of Enterprise Business Development at Matrix Medical Network, where she generated nearly $400 million in net new revenue. Her collaborative approach led to the development and implementation of successful programs for Medicare Advantage, Medicaid, commercial plans, Fortune 100 companies, and state health agencies across the country.

Howells expressed her excitement about joining Icario: “I’m joining a top-notch leadership team united in vision and strategy, and I can’t wait to get started. With advancements in AI and machine learning, Icario is uniquely positioned to personalize health interventions and optimize engagement. Consumers are tired of outdated communication tactics, and I’m excited to help Icario solidify its position as a leader in patient engagement.”

What You Should Know:

– b.well Connected Health, the leading platform for unified consumer health experiences, announced the appointment of Sarah Jones as its Chief Outcomes Officer.

– In this newly created role, Jones will oversee how b.well defines client success and ensures positive patient outcomes are aligned with long-term value for its health system, payer, and technology clients.

“Chief Outcomes Officer is not a common role in digital health,” said Alicia Raymond, Vice President of People and Culture at b.well Connected Health. Raymond highlighted that this role creation underscores b.well’s commitment to redefining digital health partnerships and prioritizing meaningful, long-term outcomes.

Sarah Jones Bio/Background

Jones brings extensive experience in healthcare and digital health to b.well. Previously, she was the Vice President of Client Success at Firefly Health, where she worked with employers to maximize quality outcomes. She also served in a leadership role at Best Buy Health following the company’s acquisition of GreatCall and Healthsense, where she led efforts to serve Medicare and Medicaid populations.